Cosmos Pharmaceutical Corp

3349 • TSE

¥6,501.00-¥85.00 (1.29%)

Estimate

P/E

16.1

EPS

404.26

Beta

0.15

Growth

Revenue, YoY

11.61%

Net income, YoY

7.68%

Forecast

P/E (FWD)

15.6

EPS (FWD)

415.845

Dividends

Dividend yield

1.37%

Annual payout

¥89.00

Next ex. div date

November 28, 26

Payout

18.54%

Div.growth, 5y

21.14%

Dividend growth streak

7 y

Div.rating

About the company

Ticker

3349

ISIN

JP3298400007

Country

Japan

Sector (GICS)

Consumer Staples

COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, energy drinks, oral and nursing care products, vitamins, health foods, diet foods, and prescriptions; and hair care and bath products. It also provides baby products, detergents, insect repellents, air fresheners, bath and toilet products, cooking supplies, gardening supplies, household and cleaning supplies, and clothing; processed foods, daily necessities, seasonings, confectionery, beverages, and alcohol; and tobacco and other products. In addition, the company engages in the maintenance and management of buildings and commercial facilities, traffic control, and security contracting activities. It sells its products through retail stores and online. COSMOS Pharmaceutical Corporation was incorporated in 1983 and is headquartered in Fukuoka City, Japan.

Frequently asked questions

What sector does Cosmos Pharmaceutical Corp (3349) operate in?

Cosmos Pharmaceutical Corp belongs to the Consumer Staples sector and operates in the Pharmaceutical Retailers industry.

What is Cosmos Pharmaceutical Corp (3349) current stock price?

As of the latest data, Cosmos Pharmaceutical Corp stock price is ¥6,501, with a previous close of ¥6,586. Cosmos Pharmaceutical Corp lost -¥85 in the last trading session, representing a -1.29% loss.

What is Cosmos Pharmaceutical Corp (3349) current market capitalization?

Cosmos Pharmaceutical Corp market cap is approximately 515.25 billion.

What is Cosmos Pharmaceutical Corp (3349) Earnings Per Share (EPS)?

The trailing EPS is ¥404, and the forward EPS is ¥416.

What is Cosmos Pharmaceutical Corp (3349) Price-to-Earnings (P/E) ratio?

Cosmos Pharmaceutical Corp current P/E ratio is 16.08, with a forward P/E of 15.63.

What is Cosmos Pharmaceutical Corp (3349) EBITDA?

Cosmos Pharmaceutical Corp EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 16.95 billion.

Does Cosmos Pharmaceutical Corp (3349) pay dividends?

Yes. Cosmos Pharmaceutical Corp pays semiannual dividends with an annualized yield of 1.37% and an estimated annual payout of ¥89 per share.

When is the next ex-dividend date for Cosmos Pharmaceutical Corp (3349)?

The next ex-dividend date is scheduled for November 28, 2026.

How did Cosmos Pharmaceutical Corp (3349) perform in its most recent earnings report?

In the last report (May 31, 2026), Cosmos Pharmaceutical Corp posted an EPS surprise of -0.05% and a revenue surprise of -73.6%.

When is Cosmos Pharmaceutical Corp (3349) next earnings report?

Cosmos Pharmaceutical Corp is expected to release its next earnings report on August 31, 2026.

What is Cosmos Pharmaceutical Corp (3349) beta (volatility) score?

Cosmos Pharmaceutical Corp has a beta of 0.150, indicating lower volatility than the overall market.